ALX Oncology Holdings Inc (ALXO) stock
ALXONasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.00+0.00 (+0.50%)
Close on Nov 17, 2026Market cap $138.97MP/E –Yield –
ALX Oncology enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
ALX Oncology's enterprise value was $26.28M on Nov 11, 2026, against $22.89M a year earlier. Over the last 5 years it ranged from -$89.27M to $677.09M, with a median of $63.60M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $26.28M | +162.0% |
| 2025 | Dec 31, 2025 | $10.03M | – |
| 2024 | Dec 31, 2024 | -$50.66M | -111.7% |
| 2023 | Dec 29, 2023 | $432.32M | +148.0% |
| 2022 | Dec 30, 2022 | $174.32M | -64.0% |
| 2021 | Dec 31, 2021 | $484.90M | -83.5% |
| 2020 | Dec 31, 2020 | $2.94B | – |
See a number that looks wrong?